Lv55
1390 积分 2024-07-22 加入
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
1小时前
已完结
CAR T cell persistence in cancer
10天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
10天前
已完结
Overcoming solid-tumor barriers: armored CAR-T cell therapy
22天前
已完结
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
1个月前
已完结
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
1个月前
已完结
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study
2个月前
已完结
Optimization of CAR T-cell dose: a debated unresolved issue
3个月前
已完结
Immunophenotype of CAR T-cells and associated apheresis products predicts clinical response in a single-center CD22 CAR T-cell therapy trial in B-cell acute lymphoblastic leukemia
3个月前
已完结
IFN-γ–resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models
3个月前
已完结
皖公网安备34019202002308
